Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 5, 2008, Pages 525-530

  Kong, Fancong ^a   Chen, Zhichao ^a   Li, Qiubai ^a   Tian, Xiaolong ^a   Zhao, Juan ^a   Yu, Ke ^a   You, Yong ^a   Zou, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; IL 6; MMPs; Multiple myeloma; NF kappaB activity; Parthenolide; VEGF

Indexed keywords

GELATINASE A; GELATINASE B; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MMP2 PROTEIN, HUMAN; PARTHENOLIDE; SESQUITERPENE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; HUMAN; METABOLISM; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN;

CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; RNA, MESSENGER; SESQUITERPENES; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58449131932     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0508-8     Document Type: Article

References (22)

1. J. F. San Miguel J. Blade Creixenti R. Garcia-Sanz 1999 Treatment of multiple myeloma Haematologica 84 36 58
2. G. Martinelli C. Terragna E. Zamagni 2000 Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma J Clin Oncol 18 2273 2281
3. M. Cavo C. Terragna G. Martinelli 2000 Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma Blood 96 355 357
4. R. M. Lemoli G. Martinelli E. Zamagni 2000 Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy Blood 95 2234 2239
5. J. Folkman 1995 Clinical applications of research on angiogenesis N Engl J Med 333 1757 1763
6. J. Folkman 1996 New perspectives in clinical oncology from angiogenesis research Eur J Cancer 14 2534 2539
7. A. Vacca D. Ribatti L. Roncali 1994 Bone marrow angiogenesis and progression in multiple myeloma Br J Haematol 87 503 508
8. S. V. Rajkumar R. Fonseca T. E. Witzig 1999 Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma Leukemia (Baltimore) 13 469 472
9. Y. M. Kim Y. M. Kim Y. M. Lee 2002 TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the Activation of Src and Phospholipase C (PLC) in human endothelial cells J Biol Chem 277 6799 6805
10. Y. Yahata Y. Shirakata S. Tokumaru 2003 Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation J Biol Chem 278 40 026 40 031
11. B. H. Kwok B. Koh M. I. Ndubuisi 2001 The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase Chem Biol 8 759 766
12. M. T. Yip-Schneider H. Nakshatri C. J. Sweeney 2005 Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-KB pathway in pancreatic carcinoma cells Mol Cancer Ther 4 4 587 594
13. S. Y. Zhang Z. N. Lin C. F. Yang 2004 Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-α-induced apoptosis in human cancer cells Carcinogenesis 25 11 2191 2199
14. J. Wen K. R. You S. Y. Lee 2002 Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide J Biol Chem 277 41 38 954 38 964
15. Y. K. Won C. N. Ong X. L. Shi 2004 Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms Carcinogenesis 25 8 1449 1458
16. Z. C. Chen Q. B. Li J. Shao 2006 Proliferation inhibiting and apoptosis inducing effects of parthenolide on human multiple myeloma cells Natl Med J China (Chinese) 86 28 1993 1996
17. B. Dankbar T. Padro R. Leo 2000 Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma Blood 95 2630 2636
18. W. T. Bellamy L. Richter Y. Frutiger 1999 Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies Cancer Res 59 728 733
19. L. Zhang S. L. Chen W. M. Chen 2005 The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma Chin J Intern Med (Chinese) 44 2 85 88
20. T. Y. Ishikawa M. Ichikawa N. Mitsuhashi 1996 Matrilysin is associated with progression of colorectal tumor Cancer Lett 107 5 12
21. A. Vacca i. D. Ribatt M. Presta 1999 Bone marrow neovascularization. Plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma Blood 93 9 3064 3072
22. X. K. Song F. J. Pan 2003 Biological activity of parthenolilde and NF-kappa B channel inhibition Chin J Gerontol (Chinese) 12 23 892 893